| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents |
1 | CycA / k20_lambdaA
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 100 | 3000 | 4 | explicit E-S complex | Substrate Rb
Product Rb_P
|
| Km ~ 0, so rate ~ kcat. Here rate = k20 * lambdaA = 10 * 3 7 Apr 2005: Fix it: rate should have substrate term in it. Set Km = 10 >> substrate. Then, kcat = Km * k20 * lambdaA = 10 * 10 * 3 = 300 |
2 | CycA / k21_phiE_A
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99968 | 2500 | 4 | explicit E-S complex | Substrate PP1A
Product PP1
|
| phiE is also used for the reaction catalyzed by A. So rates are identical to k21_phiE |
3 | CycA / Cdh1_CycA
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.01 | 12 | 4 | explicit E-S complex | Substrate Cdh1
Product Cdh1_i
|
| J4 = Km = 0.01 k4 = 40. GammaA = 0.3 kcat = k4 * GammaA = 12 |
4 | CycA / A_phosph_E2F
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 10 | 4 | explicit E-S complex | Substrate E2FA
Product E2FAP
|
| Rate equn has form [CycA].[E2F].k23 k23 = 1 MM equn has form [CycA].[E2F].kcat/(Km + E2F) So, we set kcat = Km * k23 where Km >> E2F 25 Mar. Better: Use explicit enz form. rate = k3.k1/k2 if k3 << k2. Let k3 = 1, k2 = 10, so we get k1 = k23 * 10 = 10. 6 Apr. Problem with explicit form is that the enz-substrate complex may affect the levels of the CycA, B etc. Back to MM. |
5 | CycA / A_phosph_ E2FA.Rb
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 10 | 4 | explicit E-S complex | Substrate E2FA.Rb
Product E2FAP.Rb
|
| Rate equn has form [CycA].[E2F].k23 k23 = 1 MM equn has form [CycA].[E2F].kcat/(Km + E2F) So, we set kcat = Km * k23 where Km >> E2F 25 March 2005 Use explicit form. rate = k23 = 1 = k3*k1/k2 where k3 << k2 So k3 = 1, k2 = 10, k1 = 10. 6 Apr 2005. Back to MM form because enz complex formation is depleting CycA, B etc. |
6 | CycA / Ak6_etaA
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycA_Kip1
Product CycA degraded
|
| See Ak6_etaE |
7 | CycA / k8_CycA
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.1 | 2 | 4 | explicit E-S complex | Substrate CycE
Product degraded
|
8 | CycA / k6_E_etaA
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycE_Kip1
Product CycE degraded
|
| See notes for k6_E_etaE. Explicit rates had been k1 = 500, k2 = 10, k3 = 1 but this gave a very low Km. So, back to MM: etaA = 0.5 so kcat = 500, Km = 10 as for k6_E_etaE |
9 | CycA / k6_D_etaA
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycD_Kip1
Product CycD degraded
|
| k3.k1/k2 = k6.etaA = 100*0.5 = 50 Also k3 << k2. Assume ratio is 10. Let k3 be reasonable, say 1. Then k2 = 10, k1 = 500. 6 April 2005: The above rates are bad because they give a very low Km and too much E.S. complex. So, back to MM: Km >> substrate, so Km = 10. Then kcat = Km * k6 * etaA = 10 * 100 * 0.5 = 500. |
10 | CycA / k8_CycA_Kip1
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.1 | 2 | 4 | explicit E-S complex | Substrate CycE_Kip1
Product Kip1 degraded
|
11 | CycA / k6_kip1_A
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate Kip1
Product degraded_kip
|
| k3.k1/k2 = k6.etaA = 100*0.5 = 50 Also k3 << k2. Assume ratio is 10. Let k3 be reasonable, say 1. Then k2 = 10, k1 = 500. 6 April 2005: The above rates are bad because they give a very low Km and too much E.S. complex. So, back to MM: Km >> substrate, so Km = 10. Then kcat = Km * k6 * etaA = 10 * 100 * 0.5 = 500. |
12 | CycA / k20_lambdaA[1]
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 100 | 3000 | 4 | explicit E-S complex | Substrate E2FAP.Rb
Product E2FAP Rb_P
|
| Km ~ 0, so rate ~ kcat. Here rate = k20 * lambdaA = 10 * 3 7 Apr 2005: Fix it: rate should have substrate term in it. Set Km = 10 >> substrate. Then, kcat = Km * k20 * lambdaA = 10 * 10 * 3 = 300 |
13 | CycA / k20_lambdaA[2]
| Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 100 | 3000 | 4 | explicit E-S complex | Substrate E2FA.Rb
Product E2FA Rb_P
|
| Km ~ 0, so rate ~ kcat. Here rate = k20 * lambdaA = 10 * 3 7 Apr 2005: Fix it: rate should have substrate term in it. Set Km = 10 >> substrate. Then, kcat = Km * k20 * lambdaA = 10 * 10 * 3 = 300 |
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents |
1 | CycE / Ak6_etaE | Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycA_Kip1
Product CycA degraded
|
| Rate = V6 * [CycD_Kip1]. 6 Apr 2005. Rates were k1 = 500, k2 = 10, k3 = 1 in explicit E.S reaction form. Changed to MM as Km was too low. New values: Km = 10 kcat = Km * k6 * etaE = 500. |
2 | CycA / Ak6_etaA | Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycA_Kip1
Product CycA degraded
|
| See Ak6_etaE |
3 | CycB / Ak6_etaB | Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 1000 | 4 | explicit E-S complex | Substrate CycA_Kip1
Product CycA degraded
|
| See Ak6_etaE |
4 | E2FA / k29 | Mammalian_cell_ cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 1000.02 | 50 | 4 | explicit E-S complex | Substrate Mass_dup
Product CycA
|
| Represented as eps*k29*[E2FA]*[mass], where k29 is 0.05 Split into two steps, this one deals with the E2FA term. rate = Mass_dup * E2FA * kcat / (Km + Mass_dup) Note that Mass_dup will not change. Let Km >> Mass_dup and kcat = k29 * Km. then rate ~ Mass_dup * E2FA * k29 * Km / Km |